U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950944) titled 'Efficacy and Safety of Repeated-use Middle Cut Off Membrane Dialyzers in Hemodialysis Patients' on Feb. 06, 2024.
Brief Summary: The goal of this clinical trial is to compare the efficacy of uremic toxin and inflammatory cytokine clearance by using reprocessing middle cutoff membrane (MCO) dialyzer in chronic hemodialysis patients. The main questions it aims to answer are:
* To evaluate efficacy of uremic toxin and inflammatory cytokine clearance and safty of hemodialysis with reprocessing MCO dialyzer compared with new MCO dialyzer
* To compare efficacy of uremic toxin and inflammatory cytokine clearance between 2 types of MCO dial...